New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 5, 2014
09:24 EDTARNA, MNKDMannKind shares may fall after Afrezza approval, Feuerstein says
MannKind (MNKD) shares are likely to go higher into the July 15 FDA decision on Afrezza, but are likely to sell off following the drug's approval, The Street's Adam Feuerstein argues. Feuerstein lays out similarities between MannKind and Arena Pharmaceuticals (ARNA). Reference Link
News For MNKD;ARNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 12, 2014
08:01 EDTMNKDPiper predicts two large-cap biotechs could be acquired in 2015
Subscribe for More Information
December 8, 2014
06:47 EDTARNAArena says Teva files marketing authorization of Belviq in Israel
Arena Pharmaceuticals (ARNA) disclosed late Friday that Teva Pharmaceutical's (TEVA) local Israeli subsidiary, Abic Marketing Limited, has filed for marketing authorization of Belviq in Israel. In connection with the filing, Arena will receive a milestone payment of $250K.
06:45 EDTARNAArena says Eisai withdraws Belviq application in Canada
Subscribe for More Information
06:44 EDTARNAArena Pharmaceuticals says 'small number' of Belviq labels incomplete
Subscribe for More Information
05:50 EDTMNKDStocks with implied volatility movement; AVNR MNKD
Subscribe for More Information
December 5, 2014
06:27 EDTMNKDMannKind implied volatility of 47 at lower end of index mean range
Subscribe for More Information
December 4, 2014
05:55 EDTMNKDStocks with implied volatility movement; MNKD SPLS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use